Clobetasol Propionate, 0.05%

DRUG2 trials

Sponsors

Galderma R&D

Conditions

Plaque PsoriasisPsoriasis

Phase 4

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

CompletedNCT00437255

Galderma R&DPlaque Psoriasis

Start: 2006-08-31End: 2007-06-30Updated: 2022-07-29

Unknown Phase

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

CompletedNCT00437216

Galderma R&DPsoriasis

Start: 2006-02-28End: 2006-07-31Updated: 2022-07-29